TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ARGX

argenx NV

Healthcare · Biotechnology

919.20$ -1.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 10,032 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARGX
Line item Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q4 25 Q2 26
3,134 3,194 3,194 4,542 – 4,797 – 6,203 – 7,176 8,683 10,032
– 2,692 1,889 4,124 – 4,264 – 4,883 – 5,830 6,899 8,068
– 1,111 -1,889 2,049 – 1,438 – 1,500 – 2,086 3,491 3,584
– 1,997 1,889 3,180 – 3,102 – 3,379 – 3,928 4,440 5,184
– 355 – 499 – 656 – 909 – 1,198 1,657 1,941
– 201 – 311 – 326 – 407 – 341 474 371
– 15 – – – – – – – – – –
– 16 – – – 9.4 – 6.3 – – – –
– 190 – 125 – 132 – 181 – 219 272 266
– 336 – 445 – 534 – 704 – 1,080 1,360 1,615
– 318 – 423 – 500 – 670 – 1,042 1,320 1,575
– 3.2 – 4.6 – 5.9 – 6.5 – 7.6 11 11
– 195 – 246 – 281 – 342 – 532 1,267 718
– 2,858 2,703 4,098 – 4,262 – 5,498 – 6,096 7,323 8,417
– -2,233 – -2,405 – -2,437 – -1,572 – -1,157 -280 558
56 56 58 58 59 59 66 71 66 66 66 64

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?